145 related articles for article (PubMed ID: 37973882)
1. Clinical complications after a traumatic brain injury and its relation with brain biomarkers.
Yuguero O; Bernal M; Farré J; Martinez-Alonso M; Vena A; Purroy F
Sci Rep; 2023 Nov; 13(1):20057. PubMed ID: 37973882
[TBL] [Abstract][Full Text] [Related]
2. Platelet levels and age are determinants of survival after mild-moderate TBI: A prospective study in Spain.
Yuguero O; Vena A; Bernal M; Martínez-Alonso M; Farre J; Purroy F
Front Public Health; 2023; 11():1109426. PubMed ID: 37020814
[TBL] [Abstract][Full Text] [Related]
3. Point-of-Care Platform Blood Biomarker Testing of Glial Fibrillary Acidic Protein versus S100 Calcium-Binding Protein B for Prediction of Traumatic Brain Injuries: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Study.
Okonkwo DO; Puffer RC; Puccio AM; Yuh EL; Yue JK; Diaz-Arrastia R; Korley FK; Wang KKW; Sun X; Taylor SR; Mukherjee P; Markowitz AJ; Jain S; Manley GT;
J Neurotrauma; 2020 Dec; 37(23):2460-2467. PubMed ID: 32854584
[TBL] [Abstract][Full Text] [Related]
4. Blood biomarkers on admission in acute traumatic brain injury: Relations to severity, CT findings and care path in the CENTER-TBI study.
Czeiter E; Amrein K; Gravesteijn BY; Lecky F; Menon DK; Mondello S; Newcombe VFJ; Richter S; Steyerberg EW; Vyvere TV; Verheyden J; Xu H; Yang Z; Maas AIR; Wang KKW; Büki A;
EBioMedicine; 2020 Jun; 56():102785. PubMed ID: 32464528
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of day-of-injury plasma GFAP and UCH-L1 concentrations for predicting functional recovery after traumatic brain injury in patients from the US TRACK-TBI cohort: an observational cohort study.
Korley FK; Jain S; Sun X; Puccio AM; Yue JK; Gardner RC; Wang KKW; Okonkwo DO; Yuh EL; Mukherjee P; Nelson LD; Taylor SR; Markowitz AJ; Diaz-Arrastia R; Manley GT;
Lancet Neurol; 2022 Sep; 21(9):803-813. PubMed ID: 35963263
[TBL] [Abstract][Full Text] [Related]
6. Serial measurement of S100B and NSE in pediatric traumatic brain injury.
Park DW; Park SH; Hwang SK
Childs Nerv Syst; 2019 Feb; 35(2):343-348. PubMed ID: 30171330
[TBL] [Abstract][Full Text] [Related]
7. Characteristics and prognosis of patients admitted to a hospital emergency department for traumatic brain injury and with anticoagulant or antiplatelet treatment.
Yuguero O; Guzman M; Castañ T; Forné C; Galindo G; Pujol J
Neurocirugia (Astur : Engl Ed); 2018; 29(5):233-239. PubMed ID: 29898869
[TBL] [Abstract][Full Text] [Related]
8. Increases of Plasma Levels of Glial Fibrillary Acidic Protein, Tau, and Amyloid β up to 90 Days after Traumatic Brain Injury.
Bogoslovsky T; Wilson D; Chen Y; Hanlon D; Gill J; Jeromin A; Song L; Moore C; Gong Y; Kenney K; Diaz-Arrastia R
J Neurotrauma; 2017 Jan; 34(1):66-73. PubMed ID: 27312416
[TBL] [Abstract][Full Text] [Related]
9. The Levels of Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 During the First Week After a Traumatic Brain Injury: Correlations With Clinical and Imaging Findings.
Posti JP; Takala RS; Runtti H; Newcombe VF; Outtrim J; Katila AJ; Frantzén J; Ala-Seppälä H; Coles JP; Hossain MI; Kyllönen A; Maanpää HR; Tallus J; Hutchinson PJ; van Gils M; Menon DK; Tenovuo O
Neurosurgery; 2016 Sep; 79(3):456-64. PubMed ID: 26963330
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Serum Levels of S100 Calcium-Binding Protein B, Neuron-Specific Enolase, and Interleukin-6 in Pediatric Patients with Traumatic Brain Injury.
Park SH; Hwang SK
World Neurosurg; 2018 Oct; 118():e534-e542. PubMed ID: 30257306
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Models for Global Functional Outcome and Post-Concussion Symptoms Following Mild Traumatic Brain Injury: A Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) Study.
Mikolić A; Steyerberg EW; Polinder S; Wilson L; Zeldovich M; von Steinbuechel N; Newcombe VFJ; Menon DK; van der Naalt J; Lingsma HF; Maas AIR; van Klaveren D
J Neurotrauma; 2023 Aug; 40(15-16):1651-1670. PubMed ID: 37078144
[TBL] [Abstract][Full Text] [Related]
12. Association between Blood and Computed Tomographic Imaging Biomarkers in a Cohort of Mild Traumatic Brain Injury Patients.
Chen H; Ding VY; Zhu G; Jiang B; Li Y; Boothroyd D; Rezaii PG; Bet AM; Paulino AD; Weber A; Glushakova OY; Hayes RL; Wintermark M
J Neurotrauma; 2022 Oct; 39(19-20):1329-1338. PubMed ID: 35546284
[TBL] [Abstract][Full Text] [Related]
13. Relationship of admission blood proteomic biomarkers levels to lesion type and lesion burden in traumatic brain injury: A CENTER-TBI study.
Whitehouse DP; Monteiro M; Czeiter E; Vyvere TV; Valerio F; Ye Z; Amrein K; Kamnitsas K; Xu H; Yang Z; Verheyden J; Das T; Kornaropoulos EN; Steyerberg E; Maas AIR; Wang KKW; Büki A; Glocker B; Menon DK; Newcombe VFJ;
EBioMedicine; 2022 Jan; 75():103777. PubMed ID: 34959133
[TBL] [Abstract][Full Text] [Related]
14. Post-traumatic seizures following pediatric traumatic brain injury.
Elsamadicy AA; Koo AB; David WB; Lee V; Zogg CK; Kundishora AJ; Hong C; Reeves BC; Sarkozy M; Kahle KT; DiLuna M
Clin Neurol Neurosurg; 2021 Apr; 203():106556. PubMed ID: 33636505
[TBL] [Abstract][Full Text] [Related]
15. A Serum Protein Biomarker Panel Improves Outcome Prediction in Human Traumatic Brain Injury.
Thelin E; Al Nimer F; Frostell A; Zetterberg H; Blennow K; Nyström H; Svensson M; Bellander BM; Piehl F; Nelson DW
J Neurotrauma; 2019 Oct; 36(20):2850-2862. PubMed ID: 31072225
[TBL] [Abstract][Full Text] [Related]
16. Detection of neurofilament-H in serum as a diagnostic tool to predict injury severity in patients who have suffered mild traumatic brain injury.
Gatson JW; Barillas J; Hynan LS; Diaz-Arrastia R; Wolf SE; Minei JP
J Neurosurg; 2014 Nov; 121(5):1232-8. PubMed ID: 25192482
[TBL] [Abstract][Full Text] [Related]
17. Association of Very Early Serum Levels of S100B, Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and Spectrin Breakdown Product with Outcome in ProTECT III.
Frankel M; Fan L; Yeatts SD; Jeromin A; Vos PE; Wagner AK; Wolf BJ; Pauls Q; Lunney M; Merck LH; Hall CL; Palesch YY; Silbergleit R; Wright DW
J Neurotrauma; 2019 Oct; 36(20):2863-2871. PubMed ID: 30794101
[TBL] [Abstract][Full Text] [Related]
18. Temporal response profiles of serum ubiquitin C-terminal hydrolase-L1 and the 145-kDa alpha II-spectrin breakdown product after severe traumatic brain injury in children.
Metzger RR; Sheng X; Niedzwecki CM; Bennett KS; Morita DC; Zielinski B; Schober ME
J Neurosurg Pediatr; 2018 Oct; 22(4):369-374. PubMed ID: 29957142
[TBL] [Abstract][Full Text] [Related]
19. Plasma Anti-Glial Fibrillary Acidic Protein Autoantibody Levels during the Acute and Chronic Phases of Traumatic Brain Injury: A Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot Study.
Wang KK; Yang Z; Yue JK; Zhang Z; Winkler EA; Puccio AM; Diaz-Arrastia R; Lingsma HF; Yuh EL; Mukherjee P; Valadka AB; Gordon WA; Okonkwo DO; Manley GT; Cooper SR; Dams-O'Connor K; Hricik AJ; Inoue T; Maas AI; Menon DK; Schnyer DM; Sinha TK; Vassar MJ
J Neurotrauma; 2016 Jul; 33(13):1270-7. PubMed ID: 26560343
[TBL] [Abstract][Full Text] [Related]
20. Blood-based biomarkers for prediction of intracranial hemorrhage and outcome in patients with moderate or severe traumatic brain injury.
Anderson TN; Hwang J; Munar M; Papa L; Hinson HE; Vaughan A; Rowell SE
J Trauma Acute Care Surg; 2020 Jul; 89(1):80-86. PubMed ID: 32251265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
